Strategic Mergers Syner-G's recent acquisition of RMC Pharmaceutical Solutions expands their service offerings and client base, presenting opportunities for cross-selling regulatory, manufacturing, and development services to RMC's existing customer network.

Expanding Leadership With new appointments of Chief Commercial Officer and Chief Operating Officer, there is a focus on strengthening market outreach and operational efficiency, creating potential avenues for presenting customized solutions aligned with their strategic growth initiatives.

Biotech Focus Syner-G’s expertise in biologics, cell and gene therapies, and advanced therapeutic modalities positions them to target mid to large biotech companies seeking regulatory and manufacturing support in innovative drug development pipelines.

Financial Scope Operating with a revenue range of 100 to 250 million dollars, Syner-G has the capacity for high-value projects, especially with clients in clinical development phases requiring comprehensive CMC and regulatory services.

Industry Recognition Being recognized as a top employer boosts their reputation, providing a compelling selling point to biotech and pharma clients who value partnerships with reputable, employee-focused organizations committed to quality and innovation.